Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of hub genes correlated with diabetic retinopathy via bioinformatics methods. | Eur Rev Med Pharmacol Sci | 2023 | 37318461 | PubTator, text mining | PubMed |
| Inhibiting HIF-1 signaling alleviates HTRA1-induced RPE senescence in retinal degeneration. | Cell Commun Signal | 2023 | 37316948 | PubTator, text mining | PubMed |
| A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value. | Int J Technol Assess Health Care | 2023 | 37313789 | PubTator, text mining | PubMed |
| How to Set Up Genetic Counselling for Inherited Macular Dystrophies: Focus on Genetic Characterization. | Int J Mol Sci | 2023 | 37298674 | PubTator, text mining | PubMed |
| miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy. | Int J Mol Sci | 2023 | 37298143 | PubTator, text mining | PubMed |
| Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions. | Mol Ther Methods Clin Dev | 2023 | 37287748 | PubTator, text mining | PubMed |
| Tuning the Metabolic Stability of Visual Cycle Modulators through Modification of an RPE65 Recognition Motif. | J Med Chem | 2023 | 37279401 | PubTator, text mining | PubMed |
| Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We? | Appl Clin Genet | 2023 | 37274131 | PubTator, text mining | PubMed |
| Light at the end of the tunnel of Corti. | Mol Ther Methods Clin Dev | 2023 | 37273898 | PubTator, text mining | PubMed |
| Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa. | Elife | 2023 | 37272616 | PubTator, text mining | PubMed |
| Molecular Genetic Analysis of the Autosomal Recessive Non-Syndromic Inherited Retinitis Pigmentosa. | Cureus | 2023 | 37267051 | PubTator, text mining | PubMed |
The alleviation effects of n-butylidenephthalide on apoptosis, senescence, and tight junction impairment of retinal pigment epithelium by activating Nrf-2/HO-1 signaling pathway in early diabetic retinopathy. | Life Sci | 2023 | 37263489 | PubTator, text mining | PubMed |
| Buffering of genetic dominance by allele-specific protein complex assembly. | Sci Adv | 2023 | 37256959 | PubTator, text mining | PubMed |
| Chromophore supply modulates cone function and survival in retinitis pigmentosa mouse models. | Proc Natl Acad Sci U S A | 2023 | 37252956 | PubTator, text mining | PubMed |
| A clinically viable approach to restoring visual function using optogenetic gene therapy. | Mol Ther Methods Clin Dev | 2023 | 37251979 | PubTator, text mining | PubMed |
| Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds. | Pharmaceutics | 2023 | 37242726 | PubTator, text mining | PubMed |
| Substance P Alleviates Retinal Pigment Epithelium Dysfunction Caused by High Glucose-Induced Stress. | Life (Basel) | 2023 | 37240715 | PubTator, text mining | PubMed |
| Evidence Synthesis of Gene Therapy and Gene Editing from Different Disorders-Implications for Individuals with Rett Syndrome: A Systematic Review. | Int J Mol Sci | 2023 | 37240368 | PubTator, text mining | PubMed |
| Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort. | Int J Mol Sci | 2023 | 37240262 | PubTator, text mining | PubMed |
| A cross-sectional study to assess the clinical utility of modern visual function assessments in patients with inherited retinal disease: a mixed methods observational study protocol. | BMC Ophthalmol | 2023 | 37226218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=19